longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Virax Biolabs(VRAX.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga_article·2 Hours ago
US
WOK
-35.74%
US
MTVA
+49.55%
US
VRAX
+35.02%
benzinga_article·2 Hours ago
US
WOK
-35.74%
US
MTVA
+49.55%
US
VRAX
+35.02%

Pre-market hot trades in US stocks: Virax Biolabs pre-market up 31.91%; PulteGroup pre-market down 16.78%

Price Alert·6 Hours ago
US
VRAX
+35.02%
US
PHM
-1.19%
Price Alert·6 Hours ago
US
VRAX
+35.02%
US
PHM
-1.19%

Why Is Virax Biolabs (VRAX) Stock Trending Overnight?

fidelity·9 Hours ago
US
VRAX
+35.02%
US
FBT
-0.28%
US
SBIO
-2.06%
fidelity·9 Hours ago
US
VRAX
+35.02%
US
FBT
-0.28%
US
SBIO
-2.06%

12 Health Care Stocks Moving In Monday's Intraday Session

benzinga_article·Yesterday at 01:05
US
SBFM
-15.69%
US
VRAX
+35.02%
benzinga_article·Yesterday at 01:05
US
SBFM
-15.69%
US
VRAX
+35.02%

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·Yesterday at 20:05
US
GOSS
+5.86%
US
LTRN
-1.67%
US
AIM
-16.30%
benzinga_article·Yesterday at 20:05
US
GOSS
+5.86%
US
LTRN
-1.67%
US
AIM
-16.30%

Virax Mulls Bringing UK Biotech Startup’s Immune Profiling Platform to China, Chair Says

Yicai·05/11/2026 16:01
US
VRAX
+35.02%
Yicai·05/11/2026 16:01
US
VRAX
+35.02%

Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders | VRAX Stock News

StockTitan·04/14/2026 11:35
US
VRAX
+35.02%
US
PBE
-0.24%
US
FBT
-0.28%
StockTitan·04/14/2026 11:35
US
VRAX
+35.02%
US
PBE
-0.24%
US
FBT
-0.28%
© 2026 Longbridge|Disclaimer

Event Tracking

May11
Virax Biolabs Considers Introducing T-Cell Immune Analysis Platform to China
08:04
Dec3
Virax Biolabs Group Ltd Completes First UK Clinical Trial Recruitment and Advances Scientific Dossier
12:34
Virax Biolabs released FY2026 Semi-Annual earnings on December 2, 2025 (EST) with actual revenue of USD 1.608 K and EPS of USD -0.491
04:00
Virax Biolabs released FY2026 Q2 earnings on December 2, 2025 (EST), actual revenue USD 804 (forecast USD 10 K), actual EPS USD -0.2455 (forecast USD -0.34)
04:00
Virax Biolabs released FY2026 Q1 earnings on December 2, 2025 (EST), actual revenue USD 804 (forecast USD 10K), actual EPS USD -0.2455 (forecast USD -0.34)
04:00
Nov3
Virax Biolabs Group Ltd. Completes UK Clinical Study and Plans US Research in 2026
13:30

Schedules & Filings

Schedules
Filings
Dec2
Earning Release(EST)

FY2026 Q2 Earning Release (USD) Revenue 804, Net Income -1.169 M, EPS -0.2455

Jul2
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 689, Net Income -1.652 M, EPS -0.3792

Nov20
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.476 K, Net Income -1.378 M, EPS -0.4449

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
AMST
2.195
+179.23%
+1.406
INM
1.470
+115.95%
+0.789
WNW
4.740
+96.68%
+2.341
CODX
2.460
+79.56%
+1.040
PHOE
20.050
+60.40%
+7.550
GIPR
0.3725
+52.73%
+0.133
MTVA
1.648
+48.44%
+0.538
BAYAR
0.1500
+43.54%
+0.045
VRAX
0.3200
+36.17%
+0.081
RUBI
2.320
+34.11%
+0.608
View More